232 related articles for article (PubMed ID: 24692283)
1. MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.
Shi LJ; Zhang CY; Zhou ZT; Ma JY; Liu Y; Bao ZX; Jiang WW
Head Neck; 2015 Jul; 37(7):970-6. PubMed ID: 24692283
[TBL] [Abstract][Full Text] [Related]
2. microRNA expression profiles in oral squamous cell carcinoma.
Soga D; Yoshiba S; Shiogama S; Miyazaki H; Kondo S; Shintani S
Oncol Rep; 2013 Aug; 30(2):579-83. PubMed ID: 23708842
[TBL] [Abstract][Full Text] [Related]
3. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
4. Alterations in miRNA expression patterns in whole blood of OSCC patients.
Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
[TBL] [Abstract][Full Text] [Related]
5. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
[TBL] [Abstract][Full Text] [Related]
6. miRNA expression profiles of oral squamous cell carcinomas.
Gombos K; Horváth R; Szele E; Juhász K; Gocze K; Somlai K; Pajkos G; Ember I; Olasz L
Anticancer Res; 2013 Apr; 33(4):1511-7. PubMed ID: 23564792
[TBL] [Abstract][Full Text] [Related]
7. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
Ni ZY; Lin FO; Liu DF; Xiao J
Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
11. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
16. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
Sun L; Liu L; Fu H; Wang Q; Shi Y
Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
Gao L; Ren W; Chang S; Guo B; Huang S; Li M; Guo Y; Li Z; Song T; Zhi K; Huang C
Onkologie; 2013; 36(4):194-9. PubMed ID: 23548968
[TBL] [Abstract][Full Text] [Related]
20. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
